MedPath

Ranitidine

Ranitidine Tablets USP, 150 mg and 300 mg

Approved
Approval ID

e24b34ec-d779-4c99-a9e9-0a3bdee39f0c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 7, 2020

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ranitidine

PRODUCT DETAILS

NDC Product Code71335-1621
Application NumberANDA078542
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 7, 2018
Generic NameRanitidine

INGREDIENTS (9)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
RANITIDINE HYDROCHLORIDEActive
Quantity: 300 mg in 1 1
Code: BK76465IHM
Classification: ACTIM
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT

Ranitidine

PRODUCT DETAILS

NDC Product Code71335-1327
Application NumberANDA078542
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 7, 2018
Generic NameRanitidine

INGREDIENTS (9)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
RANITIDINE HYDROCHLORIDEActive
Quantity: 150 mg in 1 1
Code: BK76465IHM
Classification: ACTIM
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ranitidine - FDA Drug Approval Details